about
Poor prognosis of patients with triple-negative breast cancer can be stratified by RANK and RANKL dual expression.Androgen receptor expression on circulating tumor cells in metastatic breast cancer.Rates of immune cell infiltration in patients with triple-negative breast cancer by molecular subtypeImpact of change in body mass index during neoadjuvant chemotherapy and survival among breast cancer subtypesComparison of molecular profile in triple-negative inflammatory and non-inflammatory breast cancer not of mesenchymal stem-like subtypeCooperative Effect of Oncogenic MET and PIK3CA in an HGF-Dominant Environment in Breast CancerST8SIA1 Regulates Tumor Growth and Metastasis in TNBC by Activating the FAK-AKT-mTOR Signaling PathwayPoor Response to Neoadjuvant Chemotherapy Correlates with Mast Cell Infiltration in Inflammatory Breast CancerJNK Signaling in Stem Cell Self-Renewal and DifferentiationPhase II study of Radium-223 dichloride combined with hormonal therapy for hormone receptor-positive, bone-dominant metastatic breast cancerAnti-tumor and anti-metastasis efficacy of E6201, a MEK1 inhibitor, in preclinical models of triple-negative breast cancerActivation of Canonical BMP4-SMAD7 Signaling Suppresses Breast Cancer MetastasisCorrection to: Anti-tumor and anti-metastasis efficacy of E6201, a MEK1 inhibitor, in preclinical models of triple-negative breast cancerIdentification of triple-negative breast cancer cell lines classified under the same molecular subtype using different molecular characterization techniques: Implications for translational researchQuantitative hormone receptor (HR) expression and gene expression analysis in HR+ inflammatory breast cancer (IBC) vs non-IBC
P50
Q38833288-7E6E7EB2-4632-4C88-B63A-DC425ED1268CQ42366191-6AF47008-7B2C-4E99-AC7F-2B9967E62E3BQ57472306-FB88DCD9-FF32-4595-A4F3-9A9CA5A87570Q89145851-F469DD03-0768-4FE1-BAD3-13459EC44B07Q90161213-AA25B8C5-DCFF-4002-AD20-D720759977EFQ90287282-03F9BFB2-F9CA-4CFA-8F3D-97B329DE1CE6Q91596604-0484B452-E08F-48D8-BBAD-DB253D2E0403Q91674143-822F4551-2BF6-4861-9888-5CF6B210A612Q91868860-6285A1B8-E000-4E95-ABD6-AC4DF520AD57Q92066211-E7EDB1B4-BE77-4255-B642-88C308F774B6Q92078417-98D28240-C02B-4819-9B2F-655AEBAA6411Q92667432-C45C724C-5573-4401-BDF7-0C942EBC78E0Q93081754-38C60CE8-423E-495E-A865-A9DFB3FFDCE7Q94468819-46C5765B-057D-4F07-BE2E-680CCE8BD178Q95314605-8442A794-645B-4276-9DA1-DB690C377698
P50
description
researcher
@en
wetenschapper
@nl
name
Naoto T Ueno
@en
Naoto T Ueno
@nl
type
label
Naoto T Ueno
@en
Naoto T Ueno
@nl
prefLabel
Naoto T Ueno
@en
Naoto T Ueno
@nl
P31
P496
0000-0002-0166-7275